|
(11) | EP 0 102 026 A3 |
(12) | EUROPEAN PATENT APPLICATION |
|
|
|
|||||||||||||||
(54) | Thiazole derivatives |
(57) New thiazole derivatives of the general formula I
and their salts with physiologically acceptable acids are described as well as a process for their manufacture. The new compounds exhibit histamine H-2 antagonist activity and may thus be used to inhibit gastric acid secretion and to treat gastric and peptic ulcers. |